Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 565839, 11 pages
http://dx.doi.org/10.1155/2014/565839
Research Article

The p85 Regulatory Subunit of PI3K Mediates cAMP-PKA and Insulin Biological Effects on MCF-7 Cell Growth and Motility

1Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
2Department of Biology, University Federico II of Naples, Naples, Italy
3Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Italy
4Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
5Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA

Received 18 April 2014; Revised 17 June 2014; Accepted 18 June 2014; Published 9 July 2014

Academic Editor: Elisabetta Baldi

Copyright © 2014 E. Di Zazzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. G. Hemkens, U. Grouven, R. Bender et al., “Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study,” Diabetologia, vol. 52, no. 9, pp. 1732–1744, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Currie, C. D. Poole, and E. A. M. Gale, “The influence of glucose-lowering therapies on cancer risk in type 2 diabetes,” Diabetologia, vol. 52, no. 9, pp. 1766–1777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, and M. J. Thun, “Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults,” The American Journal of Epidemiology, vol. 159, no. 12, pp. 1160–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. M. Reaven, “Pathophysiology of insulin resistance in human disease,” Physiological Reviews, vol. 75, no. 3, pp. 473–486, 1995. View at Google Scholar · View at Scopus
  6. V. Papa, V. Pezzino, A. Costantino et al., “Elevated insulin receptor content in human breast cancer,” Journal of Clinical Investigation, vol. 86, no. 5, pp. 1503–1510, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Novosyadlyy, D. E. Lann, A. Vijayakumar et al., “Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes,” Cancer Research, vol. 70, no. 2, pp. 741–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Fierz, R. Novosyadlyy, A. Vijayakumar, S. Yakar, and D. LeRoith, “Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression,” Diabetes, vol. 59, no. 3, pp. 686–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Zhang, D. H. Fagan, X. Zeng, K. T. Freeman, D. Sachdev, and D. Yee, “Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation,” Oncogene, vol. 29, no. 17, pp. 2517–2527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. Cantley, “The phosphoinositide 3-kinase pathway,” Science, vol. 296, no. 5573, pp. 1655–1657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Cain and A. J. Ridley, “Phosphoinositide 3-kinases in cell migration,” Biology of the Cell, vol. 101, no. 1, pp. 13–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Krasilnikov, “Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation,” Biochemistry, vol. 65, no. 1, pp. 59–67, 2000. View at Google Scholar · View at Scopus
  13. N. J. Hellyer, K. Cheng, and J. G. Koland, “ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase,” Biochemical Journal, vol. 333, no. 3, pp. 757–763, 1998. View at Google Scholar · View at Scopus
  14. C. J. McGlade, C. Ellis, M. Reedijk et al., “SH2 domains of the p85α subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors,” Molecular & Cellular Biology, vol. 12, no. 3, pp. 991–997, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Ciullo, G. Diez-Roux, M. Di Domenico, A. Migliaccio, and E. V. Avvedimento, “cAMP signaling selectively influences Ras effectors pathways,” Oncogene, vol. 20, no. 10, pp. 1186–1192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Cosentino, M. Di Domenico, A. Porcellini et al., “p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival,” Oncogene, vol. 26, no. 14, pp. 2095–2103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. G. De Gregorio, A. Coppa, C. Cosentino et al., “The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals,” Oncogene, vol. 26, no. 14, pp. 2039–2047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. P. French, S. Mills, R. Swarup, M. J. Bennett, and T. P. Pridmore, “Colocalization of fluorescent markers in confocal microscope images of plant cells,” Nature Protocols, vol. 3, no. 4, pp. 619–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak, and C. Sugimoto, “PI3K/Akt and apoptosis: size matters,” Oncogene, vol. 22, no. 56, pp. 8983–8998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Coffer, J. Jin, and J. R. Woodgett, “Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation,” Biochemical Journal, vol. 335, no. 1, pp. 1–13, 1998. View at Google Scholar · View at Scopus
  21. B. D. Manning, “Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis,” Journal of Cell Biology, vol. 167, no. 3, pp. 399–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Kohn, S. A. Summers, M. J. Birnbaum, and R. A. Roth, “Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation,” The Journal of Biological Chemistry, vol. 271, no. 49, pp. 31372–31378, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Jackson, M. F. White, and D. Yee, “Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells,” The Journal of Biological Chemistry, vol. 273, no. 16, pp. 9994–10003, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Luo and L. C. Cantley, “The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer,” Cell Cycle, vol. 4, no. 10, pp. 1309–1312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Luo, S. J. Field, J. Y. Lee, J. A. Engelman, and L. C. Cantley, “The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex,” Journal of Cell Biology, vol. 170, no. 3, pp. 455–464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Taniguchi, J. Winnay, T. Kondo et al., “The phosphoinositide 3-kinase regulatory subunit p85α can exert tumor suppressor properties through negative regulation of growth factor signaling,” Cancer Research, vol. 70, no. 13, pp. 5305–5315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. R. Shepherd, D. J. Withers, and K. Siddle, “Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling,” Biochemical Journal, vol. 333, part 3, pp. 471–490, 1998. View at Google Scholar · View at Scopus
  28. K. Ueki, P. Algenstaedt, F. Mauvais-Jarvis, and C. R. Kahn, “Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85α regulatory subunit,” Molecular and Cellular Biology, vol. 20, no. 21, pp. 8035–8046, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Ikegami, K. Inukai, T. Awata, T. Asano, and S. Katayama, “SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1,” Biochemical and Biophysical Research Communications, vol. 365, no. 3, pp. 433–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. L. Neal, J. Xu, P. Li et al., “Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit,” Oncogene, vol. 31, no. 7, pp. 897–906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. F. Donini, E. Di Zazzo, C. Zuchegna et al., “The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration,” International Journal of Oncology, vol. 40, no. 5, pp. 1627–1635, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. O. G. Morali, V. Delmas, R. Moore, C. Jeanney, J. P. Thiery, and L. Larue, “IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition,” Oncogene, vol. 20, no. 36, pp. 4942–4950, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kabuta, F. Hakuno, T. Asano, and S. Takahashi, “Insulin receptor substrate-3 functions as transcriptional activator in the nucleus,” Journal of Biological Chemistry, vol. 277, no. 9, pp. 6846–6851, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Soler, K. A. Thompson, R. M. Smith, and L. Jarett, “Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 17, pp. 6640–6644, 1989. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Ma, S. L. Gibson, M. A. Byrne, J. Zhang, M. F. White, and L. M. Shaw, “Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis,” Molecular and Cellular Biology, vol. 26, no. 24, pp. 9338–9351, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Leroith, “Insulin-like growth factor I receptor signaling—overlapping or redundant pathways?” Endocrinology, vol. 141, no. 4, pp. 1287–1288, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Razzini, C. P. Berrie, S. Vignati et al., “Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines,” The FASEB Journal, vol. 14, no. 9, pp. 1179–1187, 2000. View at Google Scholar · View at Scopus
  38. E. M. Fox, T. W. Miller, J. M. Balko et al., “A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer,” Cancer Research, vol. 71, no. 21, pp. 6773–6784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. N. Quayle, J. Y. Lee, L. W. T. Cheung et al., “Somatic Mutations of PIK3R1 Promote Gliomagenesis,” PLoS ONE, vol. 7, no. 11, Article ID e49466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Li, S. J. Plummer, C. L. Thompson, T. C. Tucker, and G. Casey, “Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk,” Clinical Cancer Research, vol. 14, no. 3, pp. 633–637, 2008. View at Publisher · View at Google Scholar
  41. G. Hildebrandt, J. Zierski, G. Csecsei, H. W. Mueller, and H. Stracke, “Results of continuous long term intravenous application of octreotide via an implantable pump system in acromegaly resistent to operative and X-ray therapy,” Acta Neurochirurgica, vol. 117, no. 3-4, pp. 160–165, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. K. L. Kelly and N. B. Ruderman, “Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle,” Journal of Biological Chemistry, vol. 268, no. 6, pp. 4391–4398, 1993. View at Google Scholar · View at Scopus
  43. A. Feola, A. Cimini, F. Migliucci et al., “The inhibition of p85αPI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells,” Journal of Cellular Biochemistry, vol. 114, no. 9, pp. 2114–2119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Torella, C. Gasparri, G. M. Ellison et al., “Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85α PI3K,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 6, pp. H2015–H2025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. P. J. Keely, J. K. Westwick, I. P. Whitehead, C. J. Der, and L. V. Parise, “Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K,” Nature, vol. 390, no. 6660, pp. 632–636, 1997. View at Publisher · View at Google Scholar · View at Scopus